128 related articles for article (PubMed ID: 16971117)
1. Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Richardson CM; Gillespie RJ; Williamson DS; Jordan AM; Fink A; Knight AR; Sellwood DM; Misra A
Bioorg Med Chem Lett; 2006 Dec; 16(23):5993-7. PubMed ID: 16971117
[TBL] [Abstract][Full Text] [Related]
2. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
[TBL] [Abstract][Full Text] [Related]
3. 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Mantri M; de Graaf O; van Veldhoven J; Göblyös A; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Link R; de Vries H; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2008 Aug; 51(15):4449-55. PubMed ID: 18637670
[TBL] [Abstract][Full Text] [Related]
4. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.
Slee DH; Chen Y; Zhang X; Moorjani M; Lanier MC; Lin E; Rueter JK; Williams JP; Lechner SM; Markison S; Malany S; Santos M; Gross RS; Jalali K; Sai Y; Zuo Z; Yang C; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J
J Med Chem; 2008 Mar; 51(6):1719-29. PubMed ID: 18307292
[TBL] [Abstract][Full Text] [Related]
5. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
[TBL] [Abstract][Full Text] [Related]
6. The discovery and synthesis of novel adenosine receptor (A(2A)) antagonists.
Matasi JJ; Caldwell JP; Hao J; Neustadt B; Arik L; Foster CJ; Lachowicz J; Tulshian DB
Bioorg Med Chem Lett; 2005 Mar; 15(5):1333-6. PubMed ID: 15713381
[TBL] [Abstract][Full Text] [Related]
7. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.
Slee DH; Moorjani M; Zhang X; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Jalali K; Sai Y; Zuo Z; Yang C; Wen J; O'Brien Z; Petroski R; Saunders J
J Med Chem; 2008 Mar; 51(6):1730-9. PubMed ID: 18307293
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists.
Luthra PM; Mishra CB; Jha PK; Barodia SK
Bioorg Med Chem Lett; 2010 Feb; 20(3):1214-8. PubMed ID: 20018509
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.
Gillespie RJ; Bamford SJ; Clay A; Gaur S; Haymes T; Jackson PS; Jordan AM; Klenke B; Leonardi S; Liu J; Mansell HL; Ng S; Saadi M; Simmonite H; Stratton GC; Todd RS; Williamson DS; Yule IA
Bioorg Med Chem; 2009 Sep; 17(18):6590-605. PubMed ID: 19695884
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.
Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I
Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527
[TBL] [Abstract][Full Text] [Related]
11. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2.
Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Higgins GA; Cohen-Williams ME; Varty GB; Tulshian DB
Bioorg Med Chem Lett; 2005 Aug; 15(16):3675-8. PubMed ID: 15982882
[TBL] [Abstract][Full Text] [Related]
12. Synthetic studies on selective adenosine A2A receptor antagonists: synthesis and structure-activity relationships of novel benzofuran derivatives.
Saku O; Saki M; Kurokawa M; Ikeda K; Takizawa T; Uesaka N
Bioorg Med Chem Lett; 2010 Feb; 20(3):1090-3. PubMed ID: 20034788
[TBL] [Abstract][Full Text] [Related]
13. Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Shook BC; Rassnick S; Hall D; Rupert KC; Heintzelman GR; Hansen K; Chakravarty D; Bullington JL; Scannevin RH; Magliaro B; Westover L; Carroll K; Lampron L; Russell R; Branum S; Wells K; Damon S; Youells S; Li X; Osbourne M; Demarest K; Tang Y; Rhodes K; Jackson PF
Bioorg Med Chem Lett; 2010 May; 20(9):2864-7. PubMed ID: 20347304
[TBL] [Abstract][Full Text] [Related]
14. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
[TBL] [Abstract][Full Text] [Related]
15. Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Peng H; Kumaravel G; Yao G; Sha L; Wang J; Van Vlijmen H; Bohnert T; Huang C; Vu CB; Ensinger CL; Chang H; Engber TM; Whalley ET; Petter RC
J Med Chem; 2004 Dec; 47(25):6218-29. PubMed ID: 15566292
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of the human A(2A) receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides.
Gillespie RJ; Bamford SJ; Gaur S; Jordan AM; Lerpiniere J; Mansell HL; Stratton GC
Bioorg Med Chem Lett; 2009 May; 19(10):2664-7. PubMed ID: 19362836
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
[TBL] [Abstract][Full Text] [Related]
18. Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Michielan L; Bolcato C; Federico S; Cacciari B; Bacilieri M; Klotz KN; Kachler S; Pastorin G; Cardin R; Sperduti A; Spalluto G; Moro S
Bioorg Med Chem; 2009 Jul; 17(14):5259-74. PubMed ID: 19501513
[TBL] [Abstract][Full Text] [Related]
19. 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
Lenzi O; Colotta V; Catarzi D; Varano F; Poli D; Filacchioni G; Varani K; Vincenzi F; Borea PA; Paoletta S; Morizzo E; Moro S
J Med Chem; 2009 Dec; 52(23):7640-52. PubMed ID: 19743865
[TBL] [Abstract][Full Text] [Related]
20. Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Shook BC; Rassnick S; Chakravarty D; Wallace N; Ault M; Crooke J; Barbay JK; Wang A; Leonard K; Powell MT; Alford V; Hall D; Rupert KC; Heintzelman GR; Hansen K; Bullington JL; Scannevin RH; Carroll K; Lampron L; Westover L; Russell R; Branum S; Wells K; Damon S; Youells S; Beauchamp D; Li X; Rhodes K; Jackson PF
Bioorg Med Chem Lett; 2010 May; 20(9):2868-71. PubMed ID: 20338760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
